The gastric ecosystem: assessing resident microbiome vs. transient microorganisms in obesity and following bariatric interventions
Abstract
Long considered a sterile environment due to its acidity, the stomach is increasingly recognized as a low-biomass but structured microbial ecosystem. Advances in culture-independent sequencing reveal a diverse gastric microbiome shaped by acid secretion, mucosal physiology, diet, medication use, and Helicobacter pylori colonization, although distinguishing metabolically active residents from transient oropharyngeal or dietary microorganisms remains a significant challenge. In healthy individuals, gastric mucosal communities primarily consist of Bacillota, Pseudomonadota, Actinomycetota, Bacteroidota, and Fusobacteriota, with genera such as Streptococcus , Prevotella , Rothia , and Veillonella consistently detected. Obesity is associated with altered gastric physiology, including higher pH, delayed emptying, and increased bile reflux, alongside distinct microbial signatures. Helicobacter pylori remains a dominant ecological factor modifying acidity, inflammation, and niche structure, while proton-pump inhibitors significantly “oralize” the gastric microbiome. Although animal models suggest that bariatric surgery can remodel the gastric microbiome, no human study has yet characterized gastric microbial changes following sleeve gastrectomy, gastric bypass, or endoscopic bariatric therapies, leaving the translational relevance of preclinical findings uncertain. Given the central role of the stomach in nutrient sensing and metabolic hormone secretion, its microbial ecosystem warrants dedicated investigation.
Related
- Spatial mixed models for assessing environmental exposure effects on the microbiome.
- Microbiome-driven precision psychiatry: integrating multi-omics, artificial intelligence, and personalized interventions along the gut-brain axis
- Functional microbiome shifts are associated with neuroinflammatory outcomes under dietary interventions in multiple sclerosis
- Gut microbiome-shaped chemotherapy responses across cancer types: mechanisms of resistance, biomarkers, and targeted interventions
- Editorial: Green biomanufacturing by industrial microorganisms: precise regulation and system optimization
BibTeX
@article{amoyel2026gastric,
title = {{The gastric ecosystem: assessing resident microbiome vs. transient microorganisms in obesity and following bariatric interventions}},
author = {Maxime Amoyel and André Bado and Tigran Poghosyan and Tiphaine Le Roy and Maude Le Gall},
journal = {npj Biofilms and Microbiomes},
year = {2026},
month = jun,
doi = {10.1038/s41522-026-01058-9},
url = {https://hal.science/hal-05715051v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The gastric ecosystem: assessing resident microbiome vs. transient microorganisms in obesity and following bariatric interventions
AU - Maxime Amoyel
AU - André Bado
AU - Tigran Poghosyan
AU - Tiphaine Le Roy
AU - Maude Le Gall
PY - 2026
DA - 2026/06/16
JO - npj Biofilms and Microbiomes
DO - 10.1038/s41522-026-01058-9
UR - https://hal.science/hal-05715051v1
AB - Long considered a sterile environment due to its acidity, the stomach is increasingly recognized as a low-biomass but structured microbial ecosystem. Advances in culture-independent sequencing reveal a diverse gastric microbiome shaped by acid secretion, mucosal physiology, diet, medication use, and Helicobacter pylori colonization, although distinguishing metabolically active residents from transient oropharyngeal or dietary microorganisms remains a significant challenge. In healthy individuals, gastric mucosal communities primarily consist of Bacillota, Pseudomonadota, Actinomycetota, Bacteroidota, and Fusobacteriota, with genera such as Streptococcus , Prevotella , Rothia , and Veillonella consistently detected. Obesity is associated with altered gastric physiology, including higher pH, delayed emptying, and increased bile reflux, alongside distinct microbial signatures. Helicobacter pylori remains a dominant ecological factor modifying acidity, inflammation, and niche structure, while proton-pump inhibitors significantly “oralize” the gastric microbiome. Although animal models suggest that bariatric surgery can remodel the gastric microbiome, no human study has yet characterized gastric microbial changes following sleeve gastrectomy, gastric bypass, or endoscopic bariatric therapies, leaving the translational relevance of preclinical findings uncertain. Given the central role of the stomach in nutrient sensing and metabolic hormone secretion, its microbial ecosystem warrants dedicated investigation.
SN - 2055-5008
ER -